​25 Crore Pills, 50 Lakh Vials, Sales of Rs 2,800 Crore: The Growth Story of 2 anti-Covid Drugs in India

The sales of remdesivir and favipiravir — which were running short of supply and saw constant SOS calls floating on social media — have gone up by over 2,000% and 700% since their launch in June 2020.

Source: Top India News- News18.com